Actemra SC drug use results survey
Phase of Trial: Phase IV
Latest Information Update: 12 Jul 2016
Price : $35 *
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 08 Jul 2016 Status changed from recruiting to completed.
- 17 Jul 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 04 Jul 2013 New trial record